IBB vs TQQQ
iShares Biotechnology ETF vs ProShares UltraPro QQQ
- • IBB has the lower expense ratio at 0.44% vs 0.78% for TQQQ.
- • TQQQ pays a higher dividend yield (0.78%).
Side-by-side metrics
| Metric | IBB | TQQQ |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.78% |
Dividend yield Trailing 12-month yield. | 0.16% | 0.78% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $32.06B |
YTD return | 30.22% | 9.87% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 4.00 |
P/E ratio | 25.48 | 28.18 |
Last price | $217.75 | $61.40 |
Inception | — | — |
Issuer | iShares | ProShares |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
TQQQ top holdings
| IQMM | ProShares GENIUS Money Market ETF | 16.89% |
| AAPL | Apple Inc | 3.76% |
| NVDA | NVIDIA Corp | 3.68% |
| MSFT | Microsoft Corp | 2.90% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About TQQQ
TQQQ (ProShares UltraPro QQQ) is 3x leveraged daily performance of the Nasdaq-100. Managed by ProShares, the fund carries $32.1B in assets under management, an expense ratio of 0.78%, a dividend yield of 0.78%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 16.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 11.1%.